DRMA
Dermata Therapeutics, Inc.
$1.41
+0.07 (+5.22%)
At close · Jul 7
Market Cap
$5.63M
Shares
4,022,143
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$7.56M
+38.5%
FY2025
Diluted EPS
-$8.16
+89.8%
FY2025
Operating Cash Flow
-$7.8M
+30.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $203.44K | — | — | — | $63.57K | -$45.61K | — | |
| $2.03M | $2.93M | $8.2M | $4.07M | $5.65M | $3.46M | $1.61M | |
| $4.05M | — | $4.31M | $3.97M | $4.02M | $4.4M | $1.57M | |
| — | $4.84M | $4.31M | — | — | — | — | |
| — | — | — | — | — | $0 | $322 | |
| $7.36M | $7.77M | $12.51M | $8.04M | $9.67M | — | — | |
| -$7.36M | -$7.77M | -$12.51M | -$8.04M | -$9.67M | -$7.86M | -$3.17M | |
| $655 | — | — | — | — | $45.61K | $197.27K | |
| $257.5K | $215.04K | $225.78K | — | — | — | — | |
| — | — | $0 | $0 | $0 | $0 | $0 | |
| -$7.1M | -$7.56M | -$12.29M | -$7.79M | -$9.61M | -$7.9M | -$3.24M | |
| — | — | — | — | -$9.61M | -$10.46M | -$3.24M | |
| — | — | — | — | $0 | $2.29M | — | |
| USD/shares | — | -$8.16 | -$80.32 | -$399.90 | -$2,088.00 | -$5,832.00 | -$4,056.00 |
| USD/shares | — | -$8.16 | -$80.32 | -$399.90 | — | — | — |
| shares | — | 926.19K | 152.97K | — | — | 1792.5967 | 796.2538 |
| shares | — | 926.19K | 152.97K | 19.49K | — | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.